Clinical Considerations in the Management of NF1-Associated Inoperable Plexiform Neurofibromas and Case Discussion

Experts discuss current and emerging targeted therapies and clinical considerations in the treatment of NF1 and inoperable plexiform neurofibromas, from Clinical Care Options (CCO)

Miriam Bornhorst, MD Carlos Romo, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Released: July 8, 2022 Expired: July 7, 2023

Downloadable slideset covering targeted therapy in inoperable plexiform neurofibromas in patients with NF1, from Clinical Care Options (CCO)

Miriam Bornhorst, MD Released: June 20, 2022

Focused, expert-authored module from Clinical Care Options (CCO): Drs Stephen Liu and Ryma Benayed discuss NRG1 testing and treatment strategies for NRG1 fusion positive cancers

Ryma Benayed, PhD Stephen V. Liu, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Released: February 2, 2022 Expired: February 1, 2023

Short slideset on second-generation TRK inhibitors selitrectinib and repotrectinib in NTRK fusion+ solid tumors, from Clinical Care Options (CCO)

George D. Demetri, MD Alexander Drilon, MD Released: November 9, 2021